Outcomes after nontraumatic subarachnoid hemorrhage at hospitals offering angioplasty for cerebral vasospasm: A national level analysis in the United States

Neurocritical Care

Volumn 15, Issue 1, 2011, Pages 34-41

  Khatri, Rakesh ^a   Tariq, Nauman ^a   Vazquez, Gabriela ^a   Suri, M Fareed K ^a   Ezzeddine, Mustapha A ^a   Qureshi, Adnan I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Angioplasty; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ADULT; ANGIOPLASTY; ARTICLE; BRAIN VASOSPASM; CONTROLLED STUDY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HOSPITAL CARE; HOSPITAL DISCHARGE; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; SURGICAL TECHNIQUE; UNITED STATES;

ADULT; AGED; ANGIOPLASTY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VASOSPASM, INTRACRANIAL;

EID: 80052620166     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-010-9423-5     Document Type: Article

References (22)

1. Zubkov YN, Nikiforov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir. 1984;70:65-79. (Pubitemid 14191588)
2. Newell DW, Eskridge JM, Mayberg MR, Grady MS, Winn HR. Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg. 1989;71:654-60. (Pubitemid 19275761)
3. Zwienenberg-Lee M, Hartman J, Rudisill N, et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: Results of a phase II multicenter, randomized, clinical trial. Stroke. 2008;39:1759-65.
4. Bederson JB, Connolly ESJ, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025.
5. Ncd for Percutaneous Transluminal Angioplasty (PTA) (20.7. http://www.cms.hhs.gov/mcd/viewncd.asp?ncd-id=20.7&ncd-version=8&basket= ncd%3A20%2E7%3A8%3APercutaneous+Transluminal+Angioplasty+%28PTA%29.
6. http://notes.bluecrossmn.com/web/medpolman.nsf/ 8178b1c14b1e9b6b8525624f0062fe9f/eb9611de760de2128625717100690182? OpenDocument&Highlight=0,percutaneous. Accessed 12 Sept 2009.
7. http://www.aetna.com/cpb/medical/data/200-299/0276.html). Accessed 12 Sept 2009.
8. Bardach NS, Zhao S, Gress DR, Lawton MT, Johnston SC. Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke. 2002;33: 1851-6. (Pubitemid 34761074)
9. Cross DWT III, Tirschwell DL, Clark MA, et al. Mortality rates after subarachnoid hemorrhage: Variations according to hospital case volume in 18 states. J Neurosurg. 2003;99:810-7. (Pubitemid 37314914)
10. Johnston SC. Effect of endovascular services and hospital volume on cerebral aneurysm treatment outcomes. Stroke. 2000;31: 111-7. (Pubitemid 30035761)
11. Qureshi AI, Suri MFK, Nasar A, et al. Changes in cost and outcome among US patients with stroke hospitalized in 1990 to 1991 and those hospitalized in 2000 to 2001. Stroke. 2007;38: 2180-4. (Pubitemid 47012287)
12. Wen SW, Kramer MS. Uses of ecologic studies in the assessment of intended treatment effects. J Clin Epidemiol. 1999;52:7-12. (Pubitemid 29064268)
13. HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/ nisoverview.jsp. 2009.
14. Shukla R, Fisher R, Fisher R. Testing of 3M's APR-DRG Risk Adjustment for Hospital Mortality Outcomes. Abstr Acad Health Serv Res Health Policy Meet. 2002;19:11.
15. Berman MF, Solomon RA, Mayer SA, Johnston SC, Yung PP. Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke. 2003;34:2200-7.
16. Mirski MA, Chang CW, Cowan R. Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: Evidence-based support for an intensivist-directed specialty ICU model of care. J Neurosurg Anesthesiol. 2001;13:83-92. (Pubitemid 32244983)
17. Suarez JI, Zaidat OO, Suri MF, et al. Length of stay and mortality in neurocritically ill patients: Impact of a specialized neurocritical care team. Crit Care Med. 2004;32:2311-7. (Pubitemid 39491814)
18. Matz PG. Editorial comment-spontaneous subarachnoid hemorrhage: Volume, experience, and outcome. Stroke. 2003;34:2206-7.
19. Matchar DB. The value of stroke prevention and treatment. Neurology. 1998;51:S31-5. (Pubitemid 28429321)
20. Bardach NS, Olson SJ, Elkins JS, et al. Regionalization of treatment for subarachnoid hemorrhage: A cost-utility analysis. Circulation. 2004;109:2207-12. (Pubitemid 38625398)
21. Shea AM, Reed SD, Curtis LH, et al. Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003. Neurosurgery. 2007;61:1131-7.
22. Pobereskin LH. Incidence and outcome of subarachnoid haemorrhage: A retrospective population based study. J Neurol Neurosurg Psychiatry. 2001;70:340-3. (Pubitemid 32250890)